Highlights from the Medical Affairs industry around the globe.Hear from Bristol Myers Squibb, learn about Apple and GSK's latest technological partnership, and dig into the evolution of the medical and pharmaceutical industries.
Clinical trials differ between drugs and medical devices. This article offers the FDA's perspective on the unique considerations necessary when conducting medical device clinical trials, and how clinical trials are evolving as a whole.
Learn about why Medical Affairs and MSLs are becoming an integral asset to the medical and pharmaceutical industries
Medical Affairs professionals often deal with Big data and personalized medicine as key components of their responsibilities
Halloran Consulting Group's Todd Halloran offers a personal perspective on virtual clinical trials as he takes the seat of the participant.
More data provided by clinical trials and studies means more of an opportunity for pharma to provide personalized medicine to patients. How the industry is using this information to transform the drug discover and development process for a stronger holistic outcome.
PharmaIQ discusses technology, clinical trials and predictive data, and GDPR